The Precinct

The Melbourne Biomedical Precinct is made up of over 40 hospitals, medical research institutes, biotechnology organsiations and universities largely collocated to the north of Melbourne’s CBD in the area extending from East Melbourne, Parkville, Carlton and North Melbourne to Royal Park in the north.

The reach of the Precinct goes beyond its geographical boundaries with collaborations with other universities, hospitals and research organisations throughout Victoria, Australia and the world.

In particular the Precinct works with other clusters around Monash, Deakin, LaTrobe and Swinburne universities and the Alfred Medical Research and Education Precinct in Victoria.

The Precinct employs tens of thousands of people including 10,000 researchers and about 7,000 biomedical, health and medical students located in the Precinct.

It consistently attracts around 23% of NHMRC funding annually, more than any other state in Australia, and has a publication citation rate twice the international average.

Precincts

There is a growing body of evidence that shows the benefit of health precincts, or clusters, to the economic and social prosperity of communities globally. Melbourne, the fastest growing city in Australia and the world’s most liveable, is no exception.

The Melbourne Biomedical Precinct’s five clinical research strengths are the areas where it will generate the strongest health and economic impact over the next 10 years.
They represent areas of comparative advantage for the Melbourne Biomedical Precinct based on research output, reputation, world-class expertise and landmark institutions and facilities.

The Melbourne Biomedical Precinct Partners have identified eight priority research platforms to position it in the global top 10. They reflect the Precinct’s clinical research strengths, as well as global health and disease trends and the future of science and discovery. Importantly, they also provide some of the greatest opportunities for commercialisation.